This mini review focuses on the ethnopharmacology, phytochemical, and biological/pharmacological activity and toxicology of the medicinal plant, Bauhinia forficata reported during 2012-2016. The results confirmed the continuous use of this plant, especially the leaves, for medicinal purposes, particularly as remedies for the treatment of diabetes and other ailments. Other new biological potential was evidenced, including anti-ulcerogenic, hypocholesterolemic, hepatoprotective and diuretic effects. Clinical and toxicological studies have advanced gradually, requiring more detailed experiments, to ensure the safe use of this plant for medication. Some new flavonoids were detected in this species, but significant differences were observed when comparing the chemical composition of its sub-species.
pressure. In addition, Bolson et al. [14] found 115 medicinal plants cited for 280 medicinal uses in the Tropical Atlantic Forest, including B. forficata, one of the most important ones, which is consumed mostly to treat endocrine, cardiovascular and gastrointestinal disorders. Yazbek et al. [24] found that B. forficata root tea is also used by rural women workers to treat menopause. Salvi et al. [25] evaluated the perception of 50 type II diabetic patients associated with the use of B. forficata. The participants used the tea provided by the research group for six months. It was observed that 88% responded that they had heard about hypoglycemic medicinal plants, and among these, 28.6% had used B. forficata tea before. Also, 64% of the participants reported increased urinary frequency, and 64% reported having fully adhered to the use of the medicinal plant to help control blood sugar at the end of the study.
Some countries, like Brazil, are rich in biodiversity, including plant species, and have great cultural diversity, which is important for the development of medicinal and herbal medicines in a sustainable way, respecting ethical principles and international commitments, and promoting wealth and social inclusion [13] .
Phytochemistry
Phenolic compounds, especially flavonoids, are the main constituents of B. forficata, particularly in its leaves, together with terpenes and steroids [2, 3] . Ferreres and co-workers [26] used HPLC-DAD-ESI/MS(n) to ascertain the authenticity of two certified and two commercial B. forficata samples. They evidenced 39 different flavonoids, with kaempferol-3-O-(2-rhamnosyl) rutinoside being verified in all the studied samples. B. forficata and B. forficata subsp. pruinosa (Vogel) Fortunato & Wunderlin showed five similar compounds related to the kaempferol derivatives; the last exhibited for the first time eight phenolic compounds, while 10 new compounds were identified in B. forficata. On the other hand, commercial B. forficata showed higher contents of quercetin derivatives, in addition to the presence of myricetin derivatives and flavonoid-(galloyl) glycosides. It is interesting to mention that different authors have proposed kaempferitrin (kaempferol-3,7-di-O-rhamnoside) as the main chemical marker for B. forficata [27, 28, 3] , whereas Pinheiro et al. [29] evidenced significant variations in the kaempferitrin content in samples collected from different geographical areas of the south of Brazil. However, the results obtained by Ferreres and co-workers [26] suggested that kaempferitrin cannot be considered as a chemical marker for all varieties of B. forficata, as it is absent in B. forficata subsp. pruinosa. However, Sayago and co-workers [30] concluded that although the content of phenolic compounds in B. forficata subsp. pruinosa is lower than in other Bauhinia species, kaempferitrin is present. Furthermore, these authors repeated the experiments with more suitable methods such as LC/ESI-MS and concluded that in fact, kaempferitrin is not produced in this taxon [31] .
Meanwhile, the literature has demonstrated discrepant chemical and biological results for some plants of the Bauhinia genus. These results are related to known factors that influence the production of bioactive principles in plants, such as seasonality, circadian rhythm, developmental stage and age, temperature, water availability, UV radiation, soil nutrients, altitude, atmospheric composition and tissue damage, and the influence of secondary metabolism [32] .
Another important point to be considered relates to the correct botanical classification, considering the similarity between some Bauhinia species. The contrast related to kaempferitrin confirmation in B. forficata reinforces the importance of these factors, with two recent investigations demonstrating negative results for this compound. A study carried out with several plants collected in Egypt, including B. forficata [33] , did not detect this compound, but its structural isomer, kaempferol-3-O-dirhamnoside was evidenced. Ecker and co-workers [34] collected B. forficata in the south of Brazil, and showed that quercetin and gallic acid were the most abundant compounds. The quantitative chemical composition of B. forficata, in descending order of significance, was quercetin = gallic acid > isoquercitin > chlorogenic acid = kaempferol > caffeic acid > rutin. More recently, Ardila and co-workers [35] performed comparisons between authentic B. forficata and samples purchased from drugstores claiming to be "Bauhinia spp. to treat diabetes". They evidenced that only two of the nine commercial samples presented characteristics similar to authentic B. forficata, based on the full HPLC-UV/PDA data.
Biological activities
Pharmacology: B. forficata is widely known for its beneficial effects in human health, being traditionally used in folk medicine in Brazil. Studies on biological activities conducted over the last five years are shown in Table 1 .
Antioxidant:
In recent years, research involving experimental techniques to determine the antioxidant content in natural products has increased in the search for new drugs [36] . This field of research is important, because several polyphenols found in plants exhibit antioxidant effects, and it appears that these chemical constituents activate mild oxidative stress to elicit a positive, beneficial response from the cells. They play a role in detoxifying the body by scavenging from reactive oxygen or nitrogen species, and also act as signaling molecules in the cross-talk mitochondriaendoplasmic reticulum and in the enzymatic pathways involved in the energy balance [37] .
The antioxidant activity of B. forficata has been widely demonstrated in the literature of the last five years, representing 48% (n = 12) of all the articles found in our review. From these, we selected the main works, to be discussed below. For example, Ferreres et al. [26] demonstrated the antioxidant activity of the extract from the leaves (two commercial samples and two certified ones), using DPPH, superoxide anion and nitric oxide assays. The B. forficata extract showed more potent effect than those of other species of the same genus. The commercial sample extracts showed better results as antiradical agents than the certified ones, which could be explained by the difference in flavonoid composition.
B. forficata infusion also showed antioxidant properties, for instance in a study conducted by Salgueiro et al. [38] , which demonstrated significant DPPH scavenging activity of B. forficata tea. This result is very interesting, given that it is the most common form in which this plant is used by the population in general. Also, significant Fe 2+ chelating activity was found, indicating that the harm caused by iron in generating oxygen species may be reduced.
Not only in vitro, but antioxidant effects were also demonstrated in animal tissues. Silva et al. [39] administered a B. forficata infusion (added to drinking water = 1 mg/mL) to diabetic mice as chronic treatment. After euthanasia, measurement of T-BARS and DCF in the livers showed that that these levels were reversed by the B. forticata infusion. Likewise, in a study conducted by Peroza et al. [40] animal brain homogenate with the addition of T-BARS concentrations in the presence of pro-oxidants was reduced by B. forficata decoction in a dose dependent manner (2.5; 6.25; 12.5; 25 ug/mL), demonstrating the antioxidant properties of this species. On the other hand, Sayago et al. [30] observed that B. variegata extract from fresh leaves presented higher antioxidant potential (T-BARS and DPH assays) compared with that of the B. forficata subsp. pruinosa samples tested. This finding was related to the predominance of flavonoids in the composition.
The antioxidant properties seem to be very different, depending on the sample tested. There are several possible reasons for this, as mentioned earlier, including climatic changes, soil quality, rainfall, and UV exposure. Ferreres et al. [26] 50 values such as 10.0 and 8.9 µg/ml. Farag et al. [33] , in Egypt, evaluated the aerial parts of B. forficata and observed a DPPH EC 50 = 152± 32 µg/mL.
Hypoglycemic:
One of the studies of B. forficata with greatest potential relates to its hypoglycemic and antidiabetic activities, observed through its use in folk medicine. Some studies found from the last five years are described below.
Cazarolli et al. [41] investigated the in vitro effect and mechanism of action of kaempferitrin on glucose uptake in soleus muscle, a known insulin target. In this work, different concentrations of kaempferitrin (10,100 and 1000 ᶯM) were used to stimulate glucose uptake. Seeking to understand the mechanisms of action, several specific insulin signaling inhibitors were used, leading the authors to conclude that the increased glucose uptake caused by kaempferitrin in muscle tissue occurs via the classical insulin signaling pathways, involving phosphoinositide 3-kinase (PI3K), MAP-Kinase (MAPK), translocation and synthesis of Glucose transporter type 4 (GLUT4), as well as stimulating glycogen synthesis. Farag et al. [33] studied eight species of Bauhinia, among them B. forficata, using chemometric analysis, in order to relate phenolic compounds found in extracts and antidiabetic activity in vitro by the alpha-glucosidase assay. The results showed that different species of Bauhinia have potential antidiabetic activity, corroborating its folk use.
Another study, by Martins et al. [42] , observed a preventive and hypoglycemic effect on the alloxan (2%) pro-diabetic effect by administration of aqueous extract from leaves of B. forficata in two different doses (40 g/L and 20 g/L) ad libitum in 20 mice. These findings also support its use. The ethanolic extract of B. forficata leaves was evaluated in relation to glucose hepatic metabolism and hypoglycemic effects in normoglycemic and streptozotocin-induced diabetic rats. The results revealed that treatment with B. forficata extract in fed and fasted diabetic rats reduced glucose and lactate production, in the model of liver perfusion and ex vivo analyses. On the other hand, the extract did not affect glycemia or hepatic glycogen levels in animals treated with 300 mg/kg orally over a period of 7 days. The authors therefore concluded that treatment with B. forficata interferes with hepatic glycolysis, glucogenesis and lactate production, but does not alter hyperglycemia in diabetic rats [43] .
Anticancer:
In works attesting to the cytotoxic effects of B. forficata, anticancer activity was the third most significant activity, representing 12% (n = 3). For example, a study by Düsman et al. [9] administered an infusion from fresh leaves of B. forficata (4. 65 g/L) , by gavage, to rats 2 h before, simultaneously, and 2 h after the use of cyclophosphamide (1.5 mg/mL), and observed no cytotoxic/mutagenic effects in bone marrow cells of Wistar rats. According to the authors, the use of B. forficata infusion may help reduce the chromosomal damage induced by chemotherapeutic Miceli et al. [8] 914 Natural Product Communications Vol. 13 (7) 2018 Cechinel-Zanchett et al.
leaf extract of B. forficata significantly reduced the melanoma cell line FO-1 at high concentrations (50 ug/mL), while the flavonoid rich fraction had no effect. The extract and fraction were also tested in Caco-2 cells, but had no effect. The authors conclude that the extract had no toxicity against the crustacean Artemia salina or against normal human lymphocytes, demonstrating potential selectivity in inhibiting cancer cell growth in melanoma cells.
Other biological activities:
In addition to the therapeutic potential already mentioned, B. forficata has also demonstrated antibacterial, anti-ulcerogenic, hypocholesterolemic and hepatoprotective activities (Table 1) . It is important to state that, based on the studies, phenolic compounds and flavonoids are the main compounds responsible for its valuable potential. However, the factor responsible for its antibacterial activity is still unknown, and this is one of many reasons to continue studying this species. On the other hand, our research group has studied B. forficata for several years, and recently discovered that pre-treatment with the flavonoid rich fraction of B. forficata leaves can attenuate intestinal mucositis in mice induced by Irinotecan in several parameters, such as diarrhea and inflammation (unpublished data). Also, we investigated, for the first time, the diuretic properties of extracts from leaves of B. forficata, and its main flavonoid kaempferitrin, in normotensive and hypertensive rats. These properties were associated with endogenous prostanoid generation. The results for other potential activities show that research beyond the traditional use is important for discovering new strategies to treat other conditions, and reaffirms the importance of continuing studies with this plant and its active principles.
Clinical trials
Although B. forficata is widely used in traditional medicine for therapeutic purposes, clinical trials are rare. In Brazil, where B. forficata is commonly used, specially by diabetic patients, Heller et al. [45] studied the hypoglycemic, anthropometric and hypotensive effects of B. forficata tea in 54 people for eight months, and found that the group that consumed the tea had decreased blood pressure and reduced weight and body mass index (BMI), compared with the control group. In addition, Zaccaron et al. [46] also evaluated the effects of B. forficata leaves in tea infusion over a period of 180 days, in patients with type 2 diabetes, and found that the treated group had reduced glucose levels. These data show that B. forficata is effective in humans, confirming the pre-clinical results.
The most recent published clinical paper was a pilot clinical study with diabetic and prediabetic individuals (n=15), who drank a dose of 0.15% as an infusion, three times a day (after meals), for three months. A significant reduction in glycated hemoglobin was observed, indicating that B. forficata may play a role in the prevention and treatment of diabetes [51] . In contrast to most studies, Pozzobon et al. [52] also evaluated diabetic patients using B. forficata tea, but found no difference between treated and nontreated groups. Also, Vanzetto et al. [53] analyzed anthropometric data from 37 patients with type 2 diabetes who consumed B. forficata tea for eight months, but found no significant difference. Mariángel et al. [54] found that the infusion of leaves of B. forficata (0.4%), twice daily for three months, and then for a period of one month without infusion as complementary therapy, altered only one parameter, showing a hypoglycemic effect by reducing 0.5% HbA1C in Chilean patients with poorly controlled type-2 diabetes (HbA1C >7%). However, other parameters, such as weight, blood pressure, total cholesterol, triglyceride and glucose levels, showed no difference after treatment. Discrepant results can be seen among the clinical evidence. This may be justified by the poor quality control still evidenced for phytotherapy products and medicinal plants [3] . Also, Bauhinia species are often confused due to their similarity, but only B. forficata has hypoglycemic effects. Another important factor that impacts the metabolite content of the plant is environmental conditions [32] .
Toxicology
Regarding toxicological studies with B. forficata leaves, only a few experiments were performed, the vast majority of evidence indicating that this plant has good potential for safe use as a medication. However, further, more detailed studies are recommended. The aqueous extract of B. forficata showed no cytotoxic activity on bone marrow cells of Wistar rats, and may contribute to reducing chromosomal damage induced by chemotherapy, through its antimutagenic activity in pre-treatment (71%), simultaneous treatment (91%), and post-treatment (95%) with cyclophosphamide [9] . In addition, Pepato et al. [55] found no tissue toxic effects of B. forficata leaf aqueous decoction measurable with enzyme markers in diabetic rats.
Ecker et al. [34] analyzed oxidative and mitochondrial parameters of aqueous-leaf extract of B. forficata in vitro, and found that at higher doses (400 mcg/mL), it caused mitochondrial damage, indicating that it may be harmful, depending on the dose used. Also, Gasparetto et al. [48] observed, by the Comet assay at 125 and 250 ug/Ml, that the ethanolic extract of leaves of B. forficata induced damage in human liver cancer cells (HepG2). According to Bonilha et al. [4] there are still no reports of toxicity in animals or in clinical trials, not only for B. forficata, but for other Bauhinia species in general. However, studies on these species are very important to guarantee the safety of the population that commonly uses them. In addition, a review by Nogueira et al. [56] showed that B. forficata may be involved in mutagenic activities and thyroid dysfuntions. In general, the results for the toxicology of this plant prompt the continuity of investigations to look for therapeutic potential of this species. Additional toxicological experiments are suggested.
In conclusion, the results obtained with B. forficata in the last five years (2012-2016) confirm some previous experimental studies, particularly in assays to determine the antidiabetic potential. It is interesting to mention that other biological potential was evidenced, including anti-ulcerogenic, hypocholesterolemic, hepatoprotective and diuretic effects. The clinical evidence so far is superficial, and further, more in-depth studies are needed, to guarantee its efficacy as a phytotherapeutic remedy. Toxicological studies have advanced very little, and more detailed experiments are needed to ensure the safety of this plant as a medication. With the use of modern analytical methods, such as LC/ESI-MS, some new flavonoids have been evidenced for this species, including some kaempferol and quercetin derivatives. Comparison between B. forficata and its subspecies pruinosa led us to conclude that the flavonoid kaempferitrin is only produced in the first taxon. The general profile of B. forficata is promising, and should encourage the development of new and exciting discoveries.
